Robbins Geller Scores Major Appellate Win for Allergan and its Shareholders
In an opinion issued today, a Ninth Circuit Court of Appeals panel held that the district court “misapplied governing Delaware law and improperly drew inferences against Plaintiffs rather than in their favor.” Order at 4. As such, the Ninth Circuit “conclude[d] that Plaintiffs’ particularlized allegations establish a reasonable doubt as to whether the Board faces a substantial likelihood of liability and as to whether the Board is protected by the business judgment rule” and reversed the district court’s dismissal of the case. Id.
The case will be remanded to the district court for further proceedings.
Read More Firm News
- The National Law Journal Recognizes Robbins Geller as 2021 Elite Trial Lawyers Finalist in Securities Litigation, Class Action, and Privacy/Data Breach Practice AreasMay 12, 2021
- Robbins Geller Partners Aelish Baig and Jessica Shinnefield Recognized as “Born Leaders” and Plaintiffs’ Lawyers Trailblazers by The National Law JournalMay 4, 2021
- Robbins Geller Secures Appellate Win After Supreme Court of New York Appellate Division Affirms Denial of Motion to Dismiss in Securities Class Action Against Alnylam Pharmaceuticals, Inc.April 30, 2021
- April 29, 2021
- April 22, 2021